SCHEMBL6097734

SCHEMBL6097734

O=C1C=C(Cl)C(=O)C(c2c[nH]c3ccccc23)=C1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCB P05771 5/20 0.54
SIRT2 Q8IXJ6 3/20 0.54
PIM1 P11309 3/20 0.54
PRKCA P17252 2/20 0.54
CCNE2 O96020 2/20 0.54
CDK4 P11802 2/20 0.54
PRKACA P17612 2/20 0.54
PRKACG P22612 2/20 0.54
PRKACB P22694 2/20 0.54
CCND1 P24385 2/20 0.54
CCNE1 P24864 2/20 0.54
CDK2 P24941 2/20 0.54
CAMK2D Q13557 2/20 0.54
PRKD3 O94806 1/20 0.54
CCNB2 O95067 1/20 0.54
ABL1 P00519 1/20 0.54
PRKCG P05129 1/20 0.54
CDK1 P06493 1/20 0.54
CCNB1 P14635 1/20 0.54
PRKCH P24723 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6098311 0.83 F7 (0.43) CAMK2DMEN1KMT2A
SCHEMBL6094956 0.83 ALDH1A1 (0.43) PRKCBSIRT2PIM1PRKCACCNE2
SCHEMBL6094623 0.81 IMPDH2 (0.45) CCNE2CDK4PRKACAPRKACGPRKACB
SCHEMBL6095486 0.81 TDO2 (0.46) CCNE2CDK4PRKACAPRKACGPRKACB
SCHEMBL6098129 0.81 EGFR (0.44) PIM1PRKACAPRKACGPRKACBCAMK2D
SCHEMBL6098483 0.81 MEN1 (0.40) PRKCBSIRT2PIM1PRKCACCNE2
SCHEMBL6095976 0.81 TSHR (0.39) PTPN1MEN1KMT2APDGFRB
SCHEMBL6095205 0.81 CSNK2A2 (0.41) PRKCBSIRT2PIM1PRKCACCNE2
SCHEMBL6096429 0.81 IGF1R (0.44) PIM1CAMK2DPDGFRB
SCHEMBL6094987 0.81 MEN1 (0.41) PRKCBMEN1HTTKMT2APDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7057052-B2 Heterocyclic quinones as pharmaceutical agents DUKE UNIVERSITY (US) 2006-06-06 US disclosed
WO-2004050014-A2 SETEROCYCLIC QUINONES AS PHARMACEUTICAL AGENTS DUKE UNIVERSITY (US) 2004-06-17 WO disclosed
US-20040063774-A1 Heterocyclic quinones as pharmaceutical agents DUKE UNIVERSITY 2004-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063774-A1 Heterocyclic quinones as pharmaceutical agents NQO1, RECQL, SDHA PRKCB 4438/4885SIRT2 317/4885PIM1 1768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.